[ad_1] <br><br>The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, to treat the "major global health challenge" of obesity. <br>[ad_2] <br> <br> <br> <br><a href="https://thehill.com/homenews/nexstar_media_wire/5632067-who-releases-new-guidance-for-glp-1-weight-loss-drugs-what-to-know/" style="font-size: 12px;color:#D5DBDB">Source link </a>